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Abstract
Clinicians face everyday the complexity of depression. Available pharmacotherapies and
psychotherapies improve patients suffering in a large part of subjects, however up to half of
patients do not respond to treatment. Clinicians may forecast to a good extent if a given patient
will respond or not, based on a number of data and sensations that emerge from face to face
assessment. Conversely, clinical predictors of non response emerging from literature are largely
unsatisfactory.
Here we try to fill this gap, suggesting a comprehensive assessment of patients that may
overcome the limitation of standardized assessments and detecting the factors that plausibly
contribute to so marked differences in depressive disorders outcome.
For this aim we present and discuss two clinical cases. Mr. A was an industrial manager who came
to psychiatric evaluation with a severe depressive episode. His employment was demanding and
the depressive episode undermined his capacity to manage it. Based on standardized assessment,
Mr. A condition appeared severe and potentially dramatic. Mrs. B was a housewife who came to
psychiatric evaluation with a moderate depressive episode. Literature predictors would suggest
Mrs. B state as associated with a more favourable outcome.
However the clinician impression was not converging with the standardized assessment and in
fact the outcome will reverse the prediction based on the initial formal standard evaluation.
Although the present report is based on two clinical cases and no generalizability is possible, a
more detailed analysis of personality, temperament, defense mechanisms, self esteem,
intelligence and social adjustment may allow to formalize the clinical impressions used by
clinicians for biologic and pharmacologic studies.
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Background
Treatment evaluation and guidelines relies mainly on
published clinical trials. Unfortunately clinicians face an
everyday clinical practice that can differ in terms of effi-
cacy and prediction of outcome. This leaded to criticize
the clinical trial method [1,2]. The difference is mainly
due to the fact that in the clinical practice a much higher
number of variables is taken into account. In fact case
reports yield much more information and are closer to
clinical practice [3]. This gap is particularly troublesome
for biologic and genetic research where effects are subtle
and wide [4,5].
As an attempt to fill this gap we are presenting two clinical
cases of depressed subjects that are much similar in terms
of traditional assessment but substantially differ when a
more detailed analysis is applied. This could constitute a
suggestion for inclusion of such detailed assessment in
clinical trials and biologic analyses.
To pursue this goal we have chosen a battery of tests that
explore the whole human complexity, according to the
holistic approach of the biopsychosocial model of medi-
cine, which considers patient illness like a combination of
a large quantity of biological, psychological and social fac-
tors interacting with each other [6], and according to
W.H.O. concept of health, like "a complete state of phys-
ical, mental and social well-being" [7].
We have therefore considered a number of features that
have been suggested, at a variable degree of certainty, as
associated with outcome [8-19]. We included in the anal-
ysis heredity, intrapsychic aspects (temperament and per-
sonality traits, personality disorders, defensive
mechanisms, locus of control, coping styles, self esteem),
cognitive features and social features. In order to measure
those features, we tried to use validated and reliable
instruments, when available. Informed consent has been
obtained by the two subjects in compliance with the Hel-
sinki Declaration in the context of approval of the local
ethical committee for the study.
Although a follow up of a large cohort of depressed sub-
jects investigated at baseline would be the correct strategy
to investigate this issue, practical limitations do not allow
such a study to be performed. The only comprehensive
naturalistic follow up to date is the STAR*D study which,
with a large effort and a multicentric approach, only tar-
gets resistant depression and it includes only a very lim-
ited number of predictive variables [20]. We therefore
propose a very preliminary strategy of comprehensive
assessment in line with the evidence of the complex pat-
tern of determinants of depressive disorders [21-24].
The use of this wide-ranging assessment is also motivated
by the fact that clinical predictors of non response emerg-
ing from literature are largely unsatisfactory [25]; so it is
currently accepted that the coexistence of a broad number
of factors contributes to the resistance to therapy response
and in this paper we have tried to investigate this issue.
The double aim of this paper is to suggest a comprehen-
sive assessment of mood disorders patients that may over-
come the limitation of standardized assessments and to
detect factors that plausibly contribute to the well known
marked differences in depressive disorders outcome.
Mr. A
Mr. A is a fifty-year-old industrial manager. Striking
politeness and respectfulness characterize him – he
defines himself a "medieval knight". His inclination
toward cooperation contributes to the fluency of inter-
views.
He describes himself like a good planner and his life style
reflects it: he got a degree in engineering with full marks at
twenty-five years old, something that made him very
proud; at twenty-six he did military service, he took the
qualifying examination and he began to work in a design
laboratory of a small business; at twenty-seven he got mar-
ried with a woman of the same age and they gave birth to
a daughter when he was thirty, an experience that he
defined hard but of immeasurable joy.
To spoil these plans several depressive episodes have
cropped up. At twenty-six years old, in the period of the
first employment, Mr. A began to suffer depressive symp-
toms: persistent sadness, loss of interest in activities, psy-
chic anxiety, weight loss (3–4 kilograms), sleeping
difficulty, especially waking too early, sluggishness, lack
of energy, tiredness, inappropriate guilt and loss of confi-
dence, thinking and concentrating difficulties. Mr. A
imputed this collapse to difficulties and incomprehen-
sions in the business framework. He came to psychiatric
evaluation and he was treated with clinical management
and pharmacological therapy (clomipramine, dose
unknown). After the therapy response and the symtoma-
tological remission, Mr. A got married and this event, in
conjunction with the experience of paternity, helped him
to become settled and to pass years of composure.
From the age of forty-five years old other three depressive
episodes followed, concomitant with stress in the com-
pany context. These three episodes, with similar symp-
tomatology of the first, occurred respectively when he was
forty-five, forty-seven and forty-eight years old. Each epi-
sode was treated with clinical management and the same
pharmacological medication (fluvoxamine 200–300 mg
and mirtazapine 15 mg), with positive response and com-Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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plete symtomatological remission. The time course of
Hamilton Rating Scale for   Depression (HAM-D) scores in
the first (index) episode at 45 years was 23 at baseline and
in the following 7 weeks was: 23, 18, 17, 16, 8, 8, 2. The
present score of his depressive symptoms   assessment,
carried out with the use of the HAM-D, is 2 (at the item 6,
Late Insomnia, 2 = Unable to fall asleep again if he gets
out of bed).
A number of stressful life events were concomitant with
the occurrence of depression, besides dissatisfactions in
job; Mr. A himself made a list of the "heavy events": the
death of his father, several organic diseases of his wife and
daughter, the country home devastated by an earthquake,
the job burden of his wife.
Moreover, two years ago, Mr. A's daughter began to show
marked psychopathology which will be diagnosed as
Bipolar Disorder, type I. Nevertheless, in this time, Mr. A
did not show other depressive signs. He referred to feel
himself changed, capable to consider events with detach-
ment, perhaps thanks both to pharmacological treatment,
which is still taking, and self-discipline learned with the
help of meditation and physical activity.
So, contrary to all expectations, Mr. A condition, at the
beginning apparently severe, has completely recovered
and, at the present time, seems to be steady.
Mrs. B
Mrs. B, a sixty-year-old small looking frightened woman
came to psychiatric evaluation after the death of her hus-
band, at fifty-one years. From the first interview her frailty
was clear. She had few hopes about her recovery.
She felt deeply depressed and anxious, with symptoms
like persistent sadness, inappropriate crying, feelings of
worthlessness, hopelessness, complete loss of self esteem,
loss of interest in activities, agitation and psychic anxiety,
appetite and weight loss, sleeping difficulty, lack of
energy, tiredness, thinking difficulty, impaired concen-
trating and making decisions, fear of the future, difficul-
ties in relationships and social withdrawal.
She lived in an isolated setting, incapable to do anything.
Difficulties to find the right pharmacological medication
became visible quite early because of the absence of any
response (amitryptiline not tolerated, amisulpiride 50
mg, citalopram 60 mg, paroxetine 50 mg, clomipramine
150 mg, pindolol 20 mg, mirtazapine 60 mg, trazodone
100 mg, lithium 600 mg, venlafaxine 375 mg, olanzapine
10 mg, fluoxetine 60 mg, all for extended periods and in
various combinations).
In truth, the first distress sign came into sight when, at the
age of twenty-seven, Mrs. B had an abortion. This awful
experience damages her everyday-life and forced her in
bed for a long time. Unfortunately, other two subsequent
abortions, at twenty-nine and thirty-two years old,
shocked Mrs. B. She described this period like character-
ized by ups and downs: the delighted moments during
pregnancy and the deep grief of lost and mourning fol-
lowed one upon the other without a break. Besides feeling
depressed, Mrs. B suffered of panic symptomatology (rac-
ing heartbeat, excessive sweating, trembling, breathless-
ness, chest discomfort, nausea, dizziness, feeling of
derealization, fear of losing control), which impaired her
life, compelling her to avoid crowded places and circum-
stances like travel by underground, tram or air.
Providentially, at the age of thirty-four years old, Mrs. B
gave birth to a son. She stopped to work (she was a tailor)
and devoted herself to her son. The uneasiness feelings
considerably diminished, even though anxiety and panic
attacks were always present.
Nevertheless, after her husband death, her condition got
worse and, at the present time, no treatment, neither clin-
ical management nor pharmacological therapy, has any
effects on mood and anxiety symptomatology. The
present score of her depressive symptoms assessment, car-
ried out with HAM-D, is 24. The score is substantially sta-
ble over time.
Besides the three abortions and the loss of her husband,
the death of both parents and two brothers has contrib-
uted to Mrs. B manifestation of depression.
Also regarding Mrs. B condition, expectations based on
standard research criteria, in this case of a good response,
were misleading.
Hereditary features
In accordance to the principles of formal genetics, sharing
a portion of genetic heritage increases the risk of being
affected by the same disease.
Both Mr. A and Mrs. B have other cases of depressive dis-
orders in their families, but with substantial differences:
Mr. A mother was affected by depressive disorder and
showed an anxious temperament; moreover, the bipolar
disorder of Mr. A daughter strengthen the genetic hypoth-
esis. On the contrary, only Mrs. B mother aunt was
affected by depression and anxiety, pharmacologically
treated. Therefore, the genetic load is more marked in Mr.
A compared to Mrs. B. This is usually an indication of
more 'typical' mood disorder compared to sporadic cases
[26] and it has been described as more responsive to treat-
ments [27,28].Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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Intrapsychic features
Temperament and personality traits
Personality can be defined as a complex of psychological
and behavioural dimensions [29,30]. Several theories
attempted to define what is personality and descriptions
of human personality are so many as theories are. Among
these, the bio-social theory of Cloninger gave an original
and successful contribution, describing a model that
incorporates both biological and socio-cultural influences
in the development of human personality [31]. His model
was based on the assumption that a part of the individ-
ual's personality is heritable. In particular, he hypothe-
sized that personality is composed both by Temperament,
the totality of traits which are heritable and stable
throughout life, and Character, the whole traits that are
influenced by socio-cultural learning and that mature
throughout life. Temperament  consists of four traits, so
called Harm Avoidance, Novelty Seeking, Reward
Dependence and Persistence. Harm Avoidance denotes
the individual's inclination to behavioral inhibition in
front of potentially dangerous stimuli and to anticipate
negative effects; Novelty Seeking relates to exploratory
behaviors and activation in response to novel stimuli;
Reward Dependence concerns relational and affective
skills but also other dependencies; finally Persistence
characterizes industrious, hard working and stable indi-
viduals despite frustration and fatigue. Character consists
of three dimensions: Self-Directedness, Cooperativeness
and Self-Transcendence. Self-Directedness expresses the
individual's competence towards autonomy, reliability
and maturity; Cooperativeness is related to social skills,
like support, collaboration and partnership; finally, Self-
Transcendence denotes the aptitude towards mysticism,
religion and idealism.
The Temperament and Character Inventory (TCI), a 240
items tool to assess individuals differences in the seven
basic dimensions of Temperament and Character [32], was
administered to both Mr. A and Mrs. B (Table 1). Mr. A
showed high scores in Harm Avoidance (100), Reward
Dependence (104), Persistence (126), Self-Directedness
(146) and Cooperativeness (132) and low scores in Nov-
elty Seeking (87) and Self-Transcendence (50). Mrs. B
showed similar scores to Mr. A in Reward Dependence
(109) and Novelty Seeking (86). In comparison with Mr.
A, she had higher scores in Harm Avoidance (128), Coop-
erativeness (147) and Self-Transcendence (66), even if
Self-Transcendence score remains low, and she had lower
scores in Self-Directedness (138) and Persistence (103).
So, Mr. A appears quite inhibited and responsible, pur-
poseful, goal-oriented and resolute. Differently, Mrs. B
seems to be much more timorous and inhibited toward
potentially dangerous stimuli or social circumstances, and
less mature and tenacious, although more collaborative.
Numerous studies have found high scores in Harm Avoid-
ance trait in samples of patients affected by mood disor-
ders [32-35]; this fact fortifies the hypothesis of a link
between depression and withdrawal like reaction to loss
or disappointment [36].
Moreover, also low Novelty Seeking and low Self-Direct-
edness represent trait markers for liability to recurrent
major depressive disorder [34,35,37].
Therefore, we can hypothesize that the higher introver-
sion and lower responsibility and maturity of Mrs. B could
have contributed to the negative outcome of therapies.
Nevertheless, it must be said that Harm Avoidance trait is
gender-specific and generally scores are higher in women
than men [38-42]. Moreover high Harm Avoidance scores
could be directly related to the depressive symptomatol-
ogy [32].
Personality disorders
Both Mr. A and Mrs. B were investigated for Axis II diag-
noses using the Structured Clinical Interview for the DSM-
IV (SCID-II) [43].
Mr. A suffers from an Obsessive-Compulsive Personality
Disorder, with symptoms like: excessive attention to
details, rules, lists, tidiness, organization, plans; excessive
conscientiousness, meticulousness, rigorousness and ide-
alism; incapability to get rid of consumed and no value
objects; rigidity and obstinacy.
Table 1: Mr. A and Mrs. B TCI scores in comparison with minimum and maximum values.
Temperament and 
Character dimensions
Minimum Scores Mr. A Mrs. B Maximum Scores
Harm Avoidance 33 100 128 165
Novelty Seeking 35 87 86 175
Reward Dependence 30 104 109 150
Persistence 35 126 103 175
Self-Directedness 40 146 138 200
Cooperativeness 36 132 147 180
Self-Transcendence 26 50 66 130Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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Differently, Mrs. B has an Avoidant Personality Disorder,
with traits like: avoidance of job activities that imply sig-
nificant interpersonal relationships due to the fear of crit-
icism and judgment; avoidance of interpersonal
relationships if there is no certainty of being accepted;
inhibition in interpersonal relationships and inadequacy
feelings; feelings of inferiority; reluctance toward new
activities. Moreover, Mrs. B shows a number of traits of
Dependent Personality Disorder (like difficulties to
express disagreement, difficulty to do things autono-
mously, fear of being alone and need of support) and sev-
eral traits of Obsessive-Compulsive Personality Disorder
(perfectionism interfering with completing activities,
excessive conscientiousness and idealism; incapability to
get rid of consumed and no value objects).
In literature, up till now, there is evidence of the fact that
the occurrence of a personality disorder is high among
depressive disorders [44] and complicates their treatment
[45,46], though evidence is not unequivocal [47].
In particular, Cluster C Personality Disorders, including
Avoidant, Dependent and Obsessive-Compulsive sub-
types, has been largely investigated. Firstly, Cluster C sub-
types seem to predominate between personality disorders
in mood disorder samples [48-52]. Secondly, it was
observed that a Cluster C diagnosis was associated with
significantly higher rates of early-onset depression [49].
Several recent studies have replicated these findings:
Nubukpo and colleagues observed that the frequency of
personality disorders was higher in patients with early-
onset depression rather than in those with late-onset
depression; moreover, between the early-onset depressed
patients, the most frequent personality disorders were
Avoidant and Dependent [53]. Thirdly, patients with both
panic disorder and major depression showed higher
Harm Avoidance levels and a greater prevalence of Cluster
C personality disorders, compared to patients with pure
disorders [54]. Moreover, Russell and colleagues, in a
study previously mentioned, observed that a Cluster C
diagnosis was associated with comorbid anxiety disorder
[49].
Finally, Cluster C subtypes emerged as robust predictors
of slowed remission from major depressive disorder. In
two different studies Viinamaki and collaborators investi-
gated whether Cluster C personality disorder is associated
with recovery from depression and found an association
between lack of recovery and presence of Cluster C per-
sonality disorder. In detail, among patients with depres-
sion alone, 54% had recovered from the disorder, but
only 16% of those with a Cluster C personality disorder
and depression recovered [55,56]. Grilo and colleagues
observed that participants with major depressive disorder
who had certain forms of coexisting personality disorder
psychopathology (Avoidant, Schizotypal or Borderline)
had a significantly longer time to remission from depres-
sion than did patients without any personality disorder
[57]. Moreover, Morse and colleagues observed that Clus-
ter C was associated with longer time-to-response during
acute treatment and non-response in continuation or
maintenance treatment. Although not statistically signifi-
cant, there was evidence of a cumulative negative impact
of Cluster C personality disorder and residual depressive
symptoms on instrumental activities of daily living during
maintenance treatment [58].
Also negative results were reported: in a sample of
depressed patients, one comorbid personality disorder
was of limited relevance to the course of the affective ill-
ness, especially if it was a Cluster C personality disorder
[59].
Nevertheless, summarizing, the large quantity of positive
studies justifies the assumption that the diagnosis of a
Cluster C personality disorder could be associated with
early-onset depression and comorbid anxiety disorder
and it hinders the alleviation of depressive symptoms in
major depression.
Consequently, we can hypothesize that Mrs. B repeated
treatment failures was due to the specific structure of her
personality, in which coincident traits of three personality
disorders have been crystallized in a maladaptive organi-
zation. These conclusions could be connected to temper-
amental considerations: actually, Cluster C personality
disorders were found related just with high Harm Avoid-
ance, low Novelty Seeking and low Self-Directedness [60],
therefore this fact makes Mrs. B personality profile
emblematic.
For what concerns Mr. A, his personality organization
appears more adaptive: in fact, he shows only one person-
ality Disorder – Obsessive-Compulsive – which further-
more probably represents an important resource for him,
especially in the job field.
Defense mechanisms
We have also considered the defense mechanisms of Mr.
A and Mrs. B, administering them the 88 items Defense
Style Questionnaire (DSQ) by M. Bond [61], recently val-
idated on Italian sample [62]. The questionnaire allows
the identification of four defensive mechanism styles, rep-
resenting groups of defenses classified from more imma-
ture, and therefore maladaptive, to more mature and
adaptive (Table 2).
This questionnaire has consented us to analyze the preva-
lent defensive styles of Mr. A and Mrs. B (Table 3). Their
scores are similar to those of healthy Italian sample [62],Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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with the exceptions of Mr. A scores in Anticipation and
Sublimation and Mrs. B scores in Reactive Formation,
Inhibition and Isolation, higher in comparison with those
of healthy sample.
Analysing scores different from the control sample, two
Mr. A defensive mechanisms are more adaptive. Anticipa-
tion and Sublimation, in which he obtained higher scores,
are mature defenses. Mr. A usually faces up to emotional
conflicts or internal and external stressful life events in
two adaptive way: 1) anticipating and prefiguring his
affective reactions towards future possible events or antic-
ipating the consequences and the solutions of these events
(Anticipation); 2) channeling potentially maladaptive
affects and impulses in socially appreciated behaviors, like
sport, sculpture and painting (Sublimation). Abraham
was the first who underlined the possible link between
depression and specific defenses like sublimation: he
describes in a brilliant way how the painter Giovanni Seg-
antini recreated in his works the love for his mother [63].
On the contrary, several Mrs. B defensive mechanisms
appear maladaptive. Reactive Formation, Inhibition and
Isolation are neurotic immature defenses. Mrs. B usually
faces up emotional conflicts or internal and external
stressful life events in three maladaptive way: 1) with
behaviours, thoughts and affects opposite to her own
unacceptable thoughts and feelings (Reactive Formation);
2) reducing relational capacity to avoid the anxiety associ-
ated to unacceptable internal conflicts (Inhibition); 3)
removing affects related to concepts and maintaining only
cognitive elements (Isolation). M. Klein, in her first stud-
ies about early anxieties, placed two different defense
mechanisms like Isolation and Splitting close together: it
can suggest that the psychological condition of Mrs. B is
nearer to a higher level of loss anxiety and it needs early
defenses [64].
We can hypothesize that the maturity of Mr. A defenses
has a protective function, while the immaturity of Mrs. B
defenses could be a further factor explaining the absence
of any therapy response. In fact, in the same line of evi-
dence, Mullen and collaborators, comparing treatment
responders and non-responders of a major depressive dis-
order sample, found that medication responders used sig-
nificantly less maladaptive defenses than did non-
responders and had a significantly higher or healthier
level of overall defensive functioning [65]. Nevertheless, it
is essential to underline that the individual defensive style
could be also modulated by depressive mood itself. More-
over, in a study over mentioned, immature defenses
seemed to be strongly related to low Self-Directedness and
both Self-Directedness scores and immature defense
scores were predictive of the presence and number of per-
sonality disorders [60]. Mrs. B particular profile supports
these data.
Locus of control
We have also considered the locus of control of Mr. A and
Mrs. B, administering them the 24 item Internal, Powerful
Others and Chance Scales (IPC Scales) by H. Levenson
[66]. The scale has been validated on Italian sample [67].
Locus of control refers to an individual's generalized
expectations concerning where control over subsequent
events resides. Hannah Levenson offered an alternative
Table 2: The defensive styles according to Bond [61].
Style 1: Reflects a regressive situation and highlights behavioural disorders. The patient appears incapable of integrating his own impulses in a 
constructive and responsible action. It includes defenses that are commonly considered immature
Autistic withdrawal, acting-out, inhibition, passive aggression, projection
Style 2: Identifies problems in relationships and includes defenses that "distort the image" more than defenses concerning action. Such a defensive 
structure disturbs the object relations while it does not interfere with social and work fulfilment; in literature these are defenses associated with 
borderline and narcissistic disorders
Splitting, primitive idealization, omnipotent devaluation
Style 3: Includes "self-sacrificing" defenses (for instance the compulsion to "appear good"); it poses problems more on the level of creative 
capabilities rather than relational ones, allowing in this last field stable object relations even if not necessarily "healthy" ones (i.e. masochistic 
relations)
Reactive formation, pseudo-altruism
Style 4: It is also defined as "adaptive"; including defenses associated with a good adjustment and a good integration
Sense of humour, repression, sublimationAnnals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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model of Rotter's original locus of control formulation
[68]. Whereas Rotter's conceptualization viewed locus of
control as unidimensional (internal to external), Leven-
son's model asserts that there are three independent
dimensions: Internal, Powerful Others and Chance.
According to Levenson's model, one can endorse each of
these dimensions of locus of control independently and at
the same time. For example, a person might simultane-
ously believe that both oneself and powerful others influ-
ence outcomes, but that chance does not. The IPC Scales
allow the identification of the three locus of control
dimensions.
Mr. A and Mrs. B scores are similar to those of healthy Ital-
ian sample [67] (Table 4).
Nevertheless, Mr. A Internal score is higher than Mrs. B
one (40 versus 28) and Mr. A Chance score is lower (18
versus 25). The prominent internal locus of control of Mr.
A represents a resource: he is certain to control events of
his own life, to obtain success thanks to hard work and to
his own capacities and talent. Mrs. B has a less strong
internal locus of control and she scarcely believes to the
influence of fortune in determining her life.
It is essential to consider that these features could also be
altered by the specific disorder outcome: Mr. A positive
response and complete stable recover could have contrib-
uted to his confidence, while Mrs. B repeated unsuccessful
treatments have certainly emphasized her feelings of pow-
erlessness.
Coping styles
Besides, we have considered the coping styles of Mr. A and
Mrs. B, administering them the 28 items Brief COPE by
Carver [69] (Table 5). It has not been validated in Italy.
The questionnaire allows the identification of fourteen
coping styles: Positive Reorganization, Attention With-
draw, Expression, Instrumental Support, Operatively Fac-
ing Up, Negation, Religion, Humor, Behavioral
Disengagement, Emotional Support, Substance Use,
Acceptation, Planning, Self Blaming.
We focused our attention on marked differences between
the two patients (≥ 4). Mr. A uses more adaptive and prag-
matic coping strategies like Operatively Facing Up, Accep-
tation and Planning. Nevertheless, Mrs. B seems to have a
positive, essential resource too: the support of Religion.
Moreover, she usually looks for advices and aids from oth-
Table 3: Mr. A and Mrs. B DSQ mean scores and healthy sample mean scores. The asterisk indicates deviance from normal values on 
the basis of standardized distance from the population mean and significance of the mechanism on the basis of the number of items.
Defense Mechanisms Healthy Men Sample Scores 
(Mean ± SD)
Mr. A Scores Healthy Women Sample Scores 
(Mean ± SD)
Mrs. B Scores
Acting-out 3.52 ± 1.77 4.8 4.06 ± 1.66 4.4
Affiliation 2.79 ± 2.05 5 3.48 ± 2.24 5
Undoing 2.67 ± 1.67 2 2.60 ± 1.80 4.33
Anticipation 4.86 ± 2.10 7.5* 4.97 ± 2.13 6.5
Passive aggressive 2.74 ± 1.47 2.8 2.81 ± 1.45 2.4
Consumption 1.94 ± 1.67 2.33 2.56 ± 1.70 1.33
Denial 1.80 ± 1.29 3.5 1.43 ± 1.32 3
Fantasy 4.52 ± 2.87 6 4.78 ± 2.83 5
Reaction formation 2.80 ± 1.60 3.8 2.93 ± 1.60 5.2*
Primitive idealization 3.14 ± 2.29 4 3.62 ± 2.58 6.5
Projective identification 0.98 ± 1.86 1 1.51 ± 2.45 5
Inhibition 2.96 ± 1.72 3.8 3.56 ± 1.84 7*
Isolation 3.10 ± 1.65 3 2.47 ± 1.59 4.5*
Help-rejecting complaining 2.22 ± 1.97 2 2.28 ± 1.96 4
Omnipotence 2.71 ± 1.61 2.5 2.27 ± 1.58 1.33
Task-orientation 4.87 ± 2.37 6.5 5.18 ± 2.12 2.5
Projection 1.62 ± 1.06 2.44 1.79 ± 1.19 2.44
Pseudo-altruism 5.69 ± 2.10 7 6.22 ± 1.91 8
Regression 2.30 ± 2.02 5 3.31 ± 2.12 6.5
Suppression 3.94 ± 2.08 5 3.58 ± 2.18 3
Withdrawal 4.56 ± 2.05 6.33 5.47 ± 1.93 7.33
Splitting 3.45 ± 2.09 4 3.40 ± 1.98 4.67
Somatization 1.97 ± 2.09 4 2.97 ± 2.28 5.5
Sublimation 2.05 ± 2.65 5* 2.60 ± 2.98 5
Humor 4.69 ± 1.84 4.33 4.57 ± 1.93 4.33Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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ers (Instrumental Support); this coping style could be the
result of Mrs. B dependent personality traits (like difficul-
ties to do things autonomously).
Self esteem
To assess Mr. A and Mrs. B self esteem we have adminis-
tered them the 10 items Self Esteem Scale by Rosenberg
[70]. We would expect to observe Mrs. B scores lower than
Mr. A ones, also considering her depressive symptomatol-
ogy. Nonetheless, contrary to all expectations, their self
esteem level did not differ. This fact is contrasting with the
observation of lower self esteem in euthymic depressed
subjects [71] and we are unable to explain this other that
some contingent factor that could have influenced it.
Cognitive features
The Wechsler Adult Intelligence Scale – Revised (WAIS-R)
[72] was administered to Mr. A and Mrs. B to evaluate
their cognitive functioning and their intelligence quo-
tient.
Mr. A Total IQ was 136, Verbal IQ 126 and Performance
IQ 138; Mrs. B obtained lower scores: Total IQ was 112,
Verbal IQ 104 and Performance IQ 121. Mr. A scores
would suggest that he has more cognitive resources than
Mrs. B, but, considering that WAIS-R assesses also the
individuals education level, we could observe that the dif-
ferences between the two scores could be due to the dis-
parity of Mr. A and Mrs. B education years (18 in the case
of Mr. A versus 5 in the case of Mrs. B). Furthermore, their
different occupations, in terms of cognitive involvement,
(industrial manager versus housewife) could influence
the outcome.
Finally, cognitive function has been found impaired dur-
ing acute episodes, particularly attention, learning and
memory, psychomotor functioning and frontal executive
functions [73] and this could be another possible expla-
nation of the difference in the two scores [74]. Consider-
ing all these observations, it is possible to state that both
patients have good cognitive resources.
Social features
Social adjustment
We have also considered the social adjustment of Mr. A
and Mrs. B (Table 6), administering them the Social
Adjustment Scale Self-Report (SAS-SR) [75]. The ques-
tionnaire has been validated in many countries including
Italy and it evaluates six adjustment areas: Work, Spare
Time, Family, Children, Family Unity, Finance.
Considering the fact that higher scores correspond to
higher impairment, we can observe that Mrs. B reported
scores that evidence some impairment in the social func-
tioning. This has been previously observed for patients
with mood disorder even in their remission phase
[71,76]. Mr. B functioning, compared with control one, is
worse in all areas, with the exception of Family field.
Moreover, comparing Mr. A and Mrs. B scores, a relevant
divergence could be detected in the Spare Time area (1.8
versus 3.2).
Since social functioning can be evaluated as an outcome
of treatment [77], Mrs. B higher social impairment has
surely been modulated by the absence of any positive
effect.
Morningness-eveningness preference
Finally, we have evaluated Mr. A and Mrs. B morningness
or eveningness preference administering them the Morn-
ingness-Eveningness Self-Assessment Questionnaire [78].
Table 5: Mr. A and Mrs. B Brief COPE mean scores. The asterisk 
indicates marked differences between the two patients (≥ 4).
Coping Styles Mr. A Scores Mrs. B Scores
Positive Reorganization 4 6
Attention Withdraw 2 5
Expression 7 5
Instrumental Support 2 7*
Operatively Facing Up 8* 4
Negation 2 3
Religion 2 8*
Humor 4 5
Behavioral Disengagement 2 5
Emotional Support 6 5
Substance Use 2 2
Acceptation 8* 4
Planning 8* 4
Self Blaming 7 4
Table 4: Mr. A and Mrs. B IPC Scales mean scores and healthy sample mean scores.
Locus of Control scales Healthy Men Sample Scores 
(Mean ± SD)
Mr. A Scores Healthy Women Sample Scores 
(Mean ± SD)
Mrs. B Scores
Internal 32.54 ± 8.35 40 30.35 ± 9.12 28
Powerful Others 18.16 ± 8.59 8 17.04 ± 8.67 9
Chance 19.16 ± 8.92 18 20.94 ± 8.40 25Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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Since mood disorders are characterized by circadian
rhythm abnormalities [79], we tried to analyze both Mr. A
and Mrs. B rhythm profile. Mr. A reported morningness
preference scores markedly higher than Mrs. B one (71
versus 47).
Recent studies showed that a single nucleotide polymor-
phism (T3111C), located in the 3' flanking region of the
human CLOCK gene, was associated with diurnal prefer-
ences of human healthy subjects, with higher eveningness
in subjects carrying at least one copy of the C allele [80].
In another study the possible role of the same polymor-
phism in the regulation of diurnal mood fluctuations dur-
ing a major depressive episode was investigated; Authors
observed a significantly worse outcome in homozygotes
for the C variant [81].
Consequently, it is possible to hypothesize a link between
eveningness and higher recurrence and, also in this case,
Mrs. B condition could be representative of this connec-
tion.
Conclusion
This manuscript aimed to analyse in depth the mixture of
aspects contributing to depressive disorders outcome. It is
interesting to consider that, from the standard assessment
point of view, Mr. A and Mrs. B differ one from another
only for what concerns therapy response: both are affected
by recurrent major depression, no major somatic or neu-
rologic disorder is present, no other DSM-IV axis I comor-
bidity. Subsequently, patients with so divergent clinical
history in standard research terms are similar. On the con-
trary, the complexity and heterogeneity of the individual
case should be meticulously taken into account.
Summarizing, we can consider Mr. A depression like
adaptive since it has facilitated detachment and a more
balanced involvement in his life. In fact, depressive disor-
der has long been explored in terms of adaptive and mala-
daptive functions [82]. Some depressive disorders, at mild
levels, can be adaptive if they enable individuals to disen-
gage from aversive environments and to relocate or elicit
new resources from the environment [83-85]. Moreover,
Mr. A meticulousness and his strict involvement in work-
ing area could have an essential protective function for
him.
On the contrary, in Mrs. B case depression has maladap-
tive functions. The impact of prior pharmacological inter-
ventions on Mrs. B may have been adversely affected by
several factors: 1) personality factors such as high Harm
Avoidance and low Novelty Seeking and Self-Directed-
ness; 2) Avoidant Personality Disorder, which prevents
Mrs. B from putting her energy in new social situations; 3)
Dependent Personality traits and their combination with
the loss of her husband; 4) immature defensive mecha-
nisms at intrapsychic level; 5) a therapeutic alliance prob-
ably based on omnipotence attributions. We can also
hypothesize a different way to react to previous losses and
aversive environments: Abraham indicates, among the
factors of melancholia, the repeating of situations of loss
and mourning [86]. This different way can be found in
specific personality organization in which is very difficult
to promote the change [87].
Subsequently, we could notice that the role of intrapsy-
chic factors as clinical predictors of non response appears
fundamental in the cases presented, especially for what
concerns the constellation of individual temperament
and personality traits, personality disorders, defensive
mechanisms and locus of control. Nevertheless, this pres-
entation has only a suggestive aim, given that no formal
(statistical) demonstration has been provided of the pre-
dictive value of the reported factors. The differences we
observed could be due to chance variations, however we
observed associations with poor outcome that were in the
direction hypothesized by the a-priori knowledge (e.g.
dependent personality profile, lack of maturity, lack of
social support) but that have never been joined in a com-
prehensive assessment.
This last point is the main limitation of our paper: as we
stated in the introduction section we did not perform a
large, prospective, cohort study with a comprehensive
assessment. Such a study would require an extraordinary
organizational and economic effort. Even the largest fund-
ing agency available to date did only organize a much
smaller follow up [20]. We are also aware that two sub-
Table 6: Mr. A and Mrs. B SAS-SR mean scores.
Social Adjustment Areas Healthy Sample Scores (Mean ± SD) Mr. A Scores Mrs. B Scores
Work 1.24 ± 0.56 1.5 1.7
Spare Time 1.77 ± 0.43 1.8 3.2
Family 1.56 ± 0.39 1.2 1.4
Children 0.76 ± 0.80 1 1.5
Family Unity 1.07 ± 0.68 1 1.7
Finance 1.25 ± 0.56 1 2Annals of General Psychiatry 2007, 6:5 http://www.annals-general-psychiatry.com/content/6/1/5
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jects, of different sex, can be only described and no gener-
alizability is possible.
The choice of the test is also a crucial point. A number of
features could be measured with a number of instru-
ments. This article is not aimed for a review of all possible
predictors [10,13,14,16,17]. We followed the guideline of
investigating features previously associated with outcome
and using validated instruments used in previous studies.
The indications we reported may therefore be of use for
larger studies where some of the features we propose
could be included. This would improve informativeness
and generalizability of clinical trial results [1,88].
Further, a more detailed dissection of depressive status
could be of benefit for biologic and specifically genetic
studies, where the small variances explained by single
gene variant require a careful control of environmental
confounders [4]. Alternatively genes may themselves con-
trol for basic features [89] such as temperament [90,91],
drug response [92], IQ [93], or complex combinations of
features [5].
In conclusion, we suggest that the inclusion of a set of
assessment that more deeply investigate the patient status
may help in filling the gap between routine clinical activ-
ity and standardized assessments for pharmacologic or
biologic studies.
Key points
- Clinical trial samples are scarcely representative of 'real'
patients
- Standardized clinical assessment is very limited and does
not take into account many subtle variables that predict
antidepressant response in the everyday clinical practice
- Those variables include personality, temperament,
defense mechanisms, self esteem and social adjustment
- Inclusion of those variables in the evaluation is costly
but increases validity and representativity for clinical and
biologic studies
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